Clinical Trials in Philadelphia

Showing 2201-2220 of 17,926 trials

Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma

NCT03076281

This randomized phase II trial studies how well metformin hydrochloride and doxycycline work in treating patients with head and neck squamous cell carcinoma that can be removed by surgery. Metformin hydrochloride may reduce the metabolic activity of cancer cells and of surrounding supportive tissue. Doxycycline may minimize toxic side effects of anti-cancer therapy. Giving metformin hydrochloride and doxycycline may work better in treating patients with head and neck squamous cell carcinoma.

LarynxLIPOral Cavity+1 more

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University7 participantsStarted Apr 2017

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2/3< 1 mile

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

NCT05721573

A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis

Inclusion Body Myositis

Abcuro, Inc.272 participantsStarted Feb 2023

Phoenix, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +42 more locations

Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Find Trials by Condition in Philadelphia

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

SAFE Workplace Intervention for People With IDD

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)

A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer